| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 56 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.28M | - | |
| CFO | 58.4K | $16.45M | - | |
| VP | 29.8K | $8.38M | - | |
| VP | 23.7K | $6.67M | - | |
| Dir | 23.2K | $6.54M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Sharp Phillip A45 | Director | Sale+OE | 33,670 | $230.49 | $7,760,736.28 | -26.8% | -7.6% | -22.0% | |
| Aug 5, 2022 | Tanguler Tolga57 | EVP, Chief Commercial Officer | Sell | 3,595 | $214.18 | $769,970.38 | -30.5% | -1.3% | -15.1% | |
| Jul 5, 2022 | Tanguler Tolga57 | EVP, Chief Commercial Officer | Sell | 1,754 | $150.00 | $263,100.00 | -50.0% | +30.6% | +27.8% | |
| Apr 1, 2022 | Paul Steven M | Director | Sale+OE | 15,000 | $170.69 | $2,560,370.82 | -23.2% | -13.8% | +18.3% | |
| Feb 9, 2022 | Sharp Phillip A45 | Director | Sale+OE | 30,000 | $150.00 | $4,500,000.00 | -100% | -15.3% | +42.4% | |
| Dec 23, 2021 | Vaishnaw Akshay56 | President, R&D | Sell | 2,879 | $190.93 | $549,698.04 | -1.3% | -16.5% | +22.4% | |
| Nov 12, 2021 | Maraganore John | Chief Executive Officer | Sale+OE | 33,978 | $171.52 | $5,827,800.61 | -3.0% | -11.7% | +26.6% | |
| Aug 13, 2021 | Maraganore John | Chief Executive Officer | Sale+OE | 33,979 | $199.78 | $6,788,195.96 | -2.9% | -12.0% | +19.0% | |
| Aug 9, 2021 | Vaishnaw Akshay56 | President, R&D | Sale+OE | 10,834 | $200.00 | $2,166,800.00 | -49.1% | -6.1% | +11.5% | |
| Aug 6, 2021 | Greenstreet Yvonne49 | President &COO | Sale+OE | 53,064 | $199.00 | $10,559,736.00 | -82.8% | -5.0% | +12.0% |